Skip to main content
Tropical Medicine and Infectious Disease logoLink to Tropical Medicine and Infectious Disease
. 2018 May 29;3(2):54. doi: 10.3390/tropicalmed3020054

Diagnostic Performance of Kato Katz Technique and Point-of-Care Circulating Cathodic Antigen Rapid Test in Diagnosing Schistosoma mansoni Infection in HIV-1 Co-Infected Adults on the Shoreline of Lake Victoria, Tanzania

Humphrey D Mazigo 1,*, Jorg Heukelbach 2,3
PMCID: PMC6073360  PMID: 30274450

Abstract

Background: The diagnostic performance of the Kato Katz (KK) technique and the point-of-care circulating cathodic antigen (POC-CCA) test in detecting S. mansoni infection in the presence of the human immunodeficiency virus-1 (HIV-1) infection has remained inconclusive. The present cross-sectional survey compared the diagnostic performance of the KK technique and the POC-CCA test in diagnosing S. mansoni infection in an adult population co-infected with HIV-1 in northwestern Tanzania. Methods: Single urine and stool samples from 979 adults were screened for S. mansoni infection using both the KK technique and POC-CCA tests. To compare the performance of the two diagnostic tests a combined artificial gold standard was created, based on either an egg-positive KK technique or a POC-CCA-positive test. Results: Based on the KK technique, the prevalence of S. mansoni was 47.3% (463/979, 95% CI: 44.2–50.4), as compared to 60.5% by the POC-CCA test (592/979; 95% CI: 57.4–63.5). The overall sensitivity and specificity of the POC-CCA test were 92.5% (95% CI: 89.4–94.9) and 73.3% (95% CI: 69.6–76.8), respectively. In the HIV-1 seropositive group, the sensitivity and specificity of the POC-CCA test were 78.1% (95% CI: 60.0–90.7) and 45.9% (95% CI: 35.8–56.3). Using a combined gold standard, the sensitivity of the POC-CCA test increased to >90% in both subgroups whereas that of the KK technique in the HIV-1 seropositive group was low (49.5%; 95% CI: 39.6–59.5). Conclusion: In the presence of HIV-1 co-infection, the KK technique attained a very low sensitivity. The POC-CCA test offers the best option for the rapid screening of S. mansoni infection in communities with a high prevalence of HIV-1 infection.

Keywords: Schistosoma mansoni, HIV-1, point-of-care circulating cathodic antigen, sensitivity, specificity, adult, Tanzania

1. Introduction

Intestinal schistosomiasis caused by Schistosoma mansoni remains one of the Neglected Tropical Diseases that is highly endemic in communities living along the shorelines of Lake Victoria in northwestern Tanzania [1,2]. The disease affects individuals of all age groups in these communities, with extremely high infection intensity [3,4,5].

Traditionally, the estimation of prevalence and intensity of S. mansoni infection in endemic areas is done using the Kato Katz (KK) technique [6]. The KK technique is regarded as a gold standard for diagnosis [6]. In addition, the KK technique provides quantitative information on egg intensity as an indicator of host helminth burden [6]. The technique is highly sensitive in areas with high endemicity levels, but less sensitive in areas where communities have light to moderate intensity of infection [7]. KK technique sensitivity can be increased by repeating stool samples to be collected and tested over consecutive days [7]. This adds more cost to the control programs and may also result in the withdrawal of study participants [7]. Moreover, the use of this technique for post-praziquantel treatment monitoring can lead to an overestimation of the effects of treatment [7].

In the past two decades, human immunodeficiency virus-1 (HIV-1) infection has been recognized as an important confounding factor in the parasitological diagnosis of S. mansoni infection using the KK technique [8,9,10,11]. In HIV-1/S. mansoni co-infected individuals, the excretion efficiency of S. mansoni eggs is reduced, with more eggs retained in the body [8,12]. Excretion of S. mansoni eggs from an infected individual is a function of the immune system determined by CD4+ Th2 type levels [11]. HIV-1 kills CD4+ Th2 cells, which may affect the excretion efficiencies of S. mansoni eggs; this in turn affects the sensitivity of the KK technique [11]. One study reported reduced S. mansoni egg excretion in HIV/S. mansoni co-infected individuals in western Kenya [11]. This has significant implications on the parasitological diagnosis of S. mansoni infection using the KK technique [11,13], especially in adult individuals likely to be co-infected with HIV-1 [10]. This can lead to a misclassification or missed diagnosis in individuals with light to moderate intensity. In addition, individuals co-infected with HIV-1 infection are likely to retain S. mansoni eggs in their bodies, which can lead to development of severe hepatosplenic morbidities [14].

To overcome these challenges, a point-of-care circulating cathodic antigen (POC-CCA) test that detects S. mansoni antigen released by live adult worms in the urine samples of infected individuals has been developed [15,16]. The test has been widely scrutinized [17] and has shown to have a higher sensitivity than the KK technique [7,16,17,18,19,20,21]. A single POC-CCA test has been shown to be more sensitive than six KK thick smears [7]. However, the performance of the KK technique and POC-CCA test in detecting S. mansoni infection in the presence of HIV-1 infection has remained inconclusive. The present survey was designed to compare the performance (sensitivity and specificity) of the KK technique and the POC-CCA test in diagnosing S. mansoni infection in the adult population either co-infected or not with HIV-1 in northwestern Tanzania.

2. Materials and Methods

2.1. Study Area

The study was performed at Sangabuye, Kayenze, Igalagala, and Igombe, four villages located at the southern shore of Lake Victoria, in the Ilemela district (32–34° E and 2–4° S), Mwanza region, northwestern Tanzania [10,22]. These are fishing villages highly endemic for S. mansoni infection [4]. A high proportion of adult individuals is co-infected with HIV-1 [10]. In these communities, Lake Victoria is the main source of water for domestic and economic use, such as washing, cooking, and fishing. Mass drug administration of praziquantel is focused on schoolchildren [1].

2.2. Study Design, Sample Size, Sampling Procedure, and Inclusion Criteria

This was a nested data analysis based on a cross-sectional study conducted between September and December 2012 [10,14,22]. It included all individuals aged 15–55 years living in the selected villages, with no history of praziquantel use in the past six months and no antiretroviral therapy for those who were diagnosed with HIV-1 infection. Participants were randomly selected from randomly-selected households. The sample included in the study and the selection criteria for the study participants have previously been described by Mazigo et al. (2014) [10].

If selected individuals declined to participate or were not present at the household after multiple attempts, a new member of the household was randomly selected. For households that remained vacant after multiple visits, a neighboring household was selected.

2.3. Data Collection

2.3.1. Questionnaire

A pre-tested questionnaire was used to collect the participant’s demographic information, history of praziquantel drug use, previous HIV-1 testing, and the outcome and history of the antiretroviral treatment.

2.3.2. Human Immunodeficiency Virus-1 Screening

Testing for HIV-1 infection followed national guidelines, which require participants to be counselled by a qualified nurse. By the time of this study, the Tanzanian algorithm for HIV testing recommended the use of the qualitative rapid tests, Determine® and UN-Gold® [23]. In all identified HIV-1-positive participants, venous blood samples were obtained for CD4+ analysis by FACSCalibur machine.

2.3.3. Parasitological Screening for Schistosoma mansoni Infection

A single stool sample was collected in a labeled container from each participant. Four thick KK smears were prepared following standard procedures [6] using a template of 41.7 mg (Vestergaard Frandsen, Lausanne, Switzerland). The prepared KK slides were independently examined after 24 h for the presence of S. mansoni eggs, and the eggs were counted and recorded. To avoid inter-observer bias, all the slides were examined by one experienced microscopist. For quality control, 10% of the negative and positive slides were re-examined by a reference technician.

2.3.4. Circulating Cathodic Antigen Test

A single urine sample was collected in a labeled container from each participant and examined for the presence of the circulating cathodic antigen (CCA) using the POC-CCA tests following the manufacturer’s instructions (Rapid Medical Diagnostic- http://www.rapid-diagnostics.com/) [16]. Trace results were considered as positive. All laboratory technicians involved in CCA testing were blinded for the KK parasitological and HIV-1 results of the study participants.

2.4. Data Analysis

A Microsoft Excel spreadsheet was used for double data entry, and data analysis was performed using Stata Version 15 (StataCorp, 2017, Stata statistical software: release 15. StataCorp LP, College Station, TX, USA). Numbers and percentages were used to describe categorical variables. A comparison of either proportions or categorical variables was done using chi-squared (χ2) or Fisher exact tests, where appropriate. For continuous variables, descriptive statistics were reported as means with standard deviation for normally distributed variables and medians with interquartile ranges (IQR) for variables that were not normally distributed.

The prevalences of S. mansoni infection based on KK technique and POC-CCA test and their 95% confidence intervals (CI) were calculated using binomial regression, controlling for the village of residence. The arithmetic mean of the S. mansoni egg counts for each participant was calculated from the counts of four KK thick smears and multiplied by 24 to obtain individual eggs per gram of feces. S. mansoni egg counts were logarithmically transformed to check for normality but only non-transformed means are presented. Mean egg counts for S. mansoni between sex and age were compared using Student t-test (two groups) or ANOVA (more than two groups). The intensity of infection was categorized according to WHO criteria, with 1–99 eggs per gram of feces (epg), 100–399 epg, ≥400 epg defined as low, moderate, and heavy intensities of infection, respectively [24].

Understanding the limitation of the KK technique in diagnosing S. mansoni infection [25], we constructed an artificial gold standard based on either the KK technique or POC-CCA positivity [26]. Thus, sensitivity, specificity, positive and negative predictive values of the POC-CCA test were calculated using two gold standards: (1) egg-positive by KK technique (as a reference standard for the diagnosis of S. mansoni infection); and (2) combined gold standard (infection-positive by either KK technique or POC-CCA-positivity [26]. The sensitivity of the POC-CCA test was calculated using egg-detection (KK technique) as reference standard for diagnosis of S. mansoni infection. Specificity, i.e., the percentage of negative individuals correctly identified as such, was calculated as described in [27] and sensitivity was calculated as a percentage of positive individuals correctly identified by the test [27]. In addition, a positive predictive value (PPV = proportion of positive test results that are truly positive) and negative predictive value (NPV = proportion of negative test results that are truly negative) are presented [27].

The sensitivity, specificity, positive and negative predictive values, positive and negative likelihood ratios of the KK and POC-CCA tests using a combined gold standard with their 95% CI were determined using the diagt or diagti command in Stata 15 (StataCorp, 2017, Stata statistical software: release 15. StataCorp LP, College Station, TX, USA), against the gold standard as described above [27]. The performance agreement between the two diagnostic tests was evaluated using Kappa statistics with their 95% CI for each of the sub-study population (i.e., general population, HIV-1 negative, HIV-1 positive). The Kappa values were interpreted according to previous classifications by Landis and Koch [28].

2.5. Ethical Considerations

Ethical approval was sought from the joint Ethical and Review Committee of Bugando Medical Centre and Catholic University of Health and Allied Sciences. The study received further ethical approval from the National Ethical Review Committee, National Institute for Medical Research, Tanzania. The study received further permission from the district administrative and division authorities. Kiswahili translated informed consent forms were used to obtain participants’ consent to participate in the study and assent for those who were aged 15–<18 years. Written informed consent was obtained from guardians/parents of all participants aged 15–<18 years. For illiterate participants, a thumb print was used to sign the consent/assent forms after a clear description of the study objectives was given to them. To maintain confidentiality, all the demographic and other clinical data of the study participants were kept in a closed cabinet and whenever the data were accessed no participant names were disclosed; only the identification number was used to identify a participant. All study participants infected with S. mansoni were treated with praziquantel (40 mg/kg) according to WHO guidelines [24].

3. Results

3.1. Characterization of Study Population

A total of 979 study participants aged 15–55 years was included in the study. Of these, 45.8% and 54.2% were male and female, respectively (Table 1). The overall mean age was 33.2 ± 10.7 years. Age categories and sex of the study participants are shown in Table 1. Other characteristics of the study participants have been described in detail previously [10,14].

Table 1.

Demographic characteristics of the study participants from four villages, Ilemela district, north-western Tanzania.

Sex Age Groups (Years) Total
15–20
N (%)
21–30
N (%)
31–40
N (%)
41–50
N (%)
51–55
N (%)
Female 82 (63.1) 179(54.4) 146(50.7) 86(57.7) 38(45.8) 531(54.2)
Male 48(36.9) 150(45.6) 142(49.3) 63(42.3) 45(54.2) 448(45.8)
Total 130 329 288 149 83 979

3.2. Prevalence of HIV-1 Infection

The overall prevalence of HIV-1 infection was 13.3% (130/979, 95% CI: 11.3–15.6). Female participants had the higher prevalence, as compared to male participants (16% vs. 10%, p < 0.01). The age groups >20 years had the highest HIV-1 seropositivity, as compared to the youngest age groups (p < 0.01); 31–40 year-olds had the highest prevalence (16.7%).

3.3. Prevalence and Intensity of Schistosoma mansoni Infection

Table 2 shows the prevalence of S. mansoni infection in relation to the demographic characteristics of the study participants and HIV-1 serostatus, and by the diagnostic method. Based on the KK technique, the overall prevalence of S. mansoni was 47.3% (463/979, 95% CI: 44.2–50.4), as compared to 60.5% by POC-CCA test (592/979; 95% CI: 57.4–63.5).

Table 2.

Prevalence of S.mansoni infection based on Kato Katz technique and point-of-care circulating cathodic antigen test, stratified by sex, age and HIV-1 infection status.

Variable N KK Technique p-Value POC-CCA Test p-Value
n (%) n (%)
Sex Female 531 212(39.9) p < 0.01 293(55.2) p < 0.01
Male 448 251(56.1) 299(66.7)
Age group (years) 15–20 130 81 (62.3) p < 0.01 99(79.1) p < 0.01
21–30 329 171(51.9) 217(65.9)
31–40 288 122(42.4) 161(55.9)
41–50 149 56(37.6) 68(45.6)
51–60 83 33(39.8) 47(56.6)
HIV-1 serostatus Positive 130 52(40.0) 0.07 98(75.4) p < 0.01
Negative 849 411(48.4) 494(58.2)
Intensity of S. mansoni infection (epg) 1–99 195 195(42.1) n/a 174(89.2) p < 0.02
100–399 126 126(27.2) 122(96.8)
≥400 142 142(40.7) 138(97.2)
Overall 979

In both the KK technique and POC-CCA test, males had a significantly higher prevalence than females (Table 2). Similarly, significant age differences in the prevalence of S. mansoni infections were noted, with the youngest age group (15–20 years) having the highest prevalence (Table 2).

The overall geometrical mean eggs per gram (GMepg) of feces was 173.75 epg (95% CI: 151.5–199.3). Male participants had the highest GMepg as compared to female participants (219.1 GMepg vs. 132.1 GMepg, t = 5.3349, p < 0.0001). There was a significant difference in GMepg between age groups (p = 0.001), with the youngest age group having the highest GMepg (277.2, 95% CI: 196.4–391.3).

Of the 130 HIV-1-seropositive individuals, 40% (52/130) had detectable S. mansoni eggs in their stool samples, whereas 75.4% (98/130) were identified as infected, based on the POC-CCA test (Table 2). On the other side, in the HIV-1-negative population, the prevalences were 48.4% and 58.2%, based on the KK technique and POC-CCA test, respectively.

3.4. Diagnostic Performance of Kato Katz Technique and Point-of-Care Circulating Cathodic Antigen Test

In the general population, among 621 individuals diagnosed positive with either diagnostic method, 158 (25.4%) individuals were missed by the KK technique, whereas only 29 (4.7%) individuals were missed by the POC-CCA technique (Table 3). In the HIV-1-seronegative group, 105 (20.3%) of 516 individuals that tested positive in either test were missed by the KK technique and only 22 (4.3%) by POC-CCA test (Table 3). In the HIV-seropositive group, the relative frequency of missed diagnosis by the KK technique was highest—53/105 (50.5%) individuals were missed by the KK technique, as compared to 7/105 (6.7%) by the POC-CCA test (Table 3). Considering the intensity of infection in Table 2, the POC-CCA test missed 10.8%, 3.2% and 2.8% of individuals who had low, moderate, and heavy intensity of infection.

Table 3.

Diagnostic performance of the point-of-care circulating cathodic antigen and the Kato-Katz technique for the diagnosis of Schistosoma mansoni infection in an adult population co-infected or not with HIV-1 infection.

Sub-Population Diagnostic Test KK Technique Total
Positive Negative
General population POC-CCA Positive 434 158 592
Negative 29 358 387
Total 463 516 979
HIV-1-seronegative POC-CCA Positive 389 105 494
Negative 22 333 355
Total 411 438 849
HIV-1-seropositive POC-CCA Positive 45 53 98
Negative 7 25 32
Total 52 78 130

KK-Kato Katz technique, POC-CCA-Point-of-care circulating cathodic antigen test.

3.5. Sensitivity and Specificity of Point-of-Care Circulating Cathodic Antigen Test

3.5.1. Using Kato Katz as a Gold Standard Technique

The overall sensitivity and specificity of the POC-CCA test using the KK technique as a gold standard technique in the general population were 92.5% and 73.3%, respectively (Table 4). In relation to HV-1 serostatus, for the HIV-1-seronegative group, the sensitivity of POC-CCA test was 93.8% and specificity was 78.7% (Table 4). For the HIV-1-seropositive group, the sensitivity and specificity were 78.1% and 45.9%, respectively (Table 4). There was a significant substantial agreement between the two tests in the general population (Kappa = 0.62, agreement = 80.9%, p < 0.001) and in the HIV-1-seronegative group (Kappa = 0.70, agreement = 85%, p < 0.001). However, a significant poor agreement between the two tests was observed in the HIV-1-seropositive group (Kappa = 0.16, agreement = 53.9%, p < 0.001).

Table 4.

Sensitivity and specificity of point-of-care circulating cathodic antigen test using the Kato Katz technique and a combined gold standard in sub-populations of study participants.

Sub-Population Sensitivity
% (95% CI)
Specificity
% (95% CI)
Positive Predictive Values
% (95% CI)
Negative Predictive Values
% (95% CI)
Kappa Statistics
Using Kato Katz technique as a gold standard
General population 92.5%
(89.4–94.9)
73.3%
(69.6–76.8)
69.4%
(65.2–73.3)
93.7%
(91.1–95.8)

0.62
HIV-1-seronegative 93.8%
(90.8–96.1)
78.7%
(74.9–82.3)
76%
(71.7–80.0)
94.6%
(92.0–96.6)

0.70
HIV-1-seropositive 78.1%
(60.0–90.7)
45.9%
(35.8–56.3)
32.1%
(21.9–43.6)
86.5%
(74.2–94.4)

0.16
Using combined gold standard
In general population 95.3%
(93.4–96.9)
100%
(99.0–100.0)
100%
(99.4–100.0)
92.5%
(89.4–94.9)
----
HIV-1-seronegative 95.7%
(93.6–97.3)
100%
(98.9–100.0)
100%
(99.3–100.0)
93.8%
(90.8–96.1)
----
HIV-1-seropositive 93.3%
(86.7–97.3)
100%
(86.3–100.0)
100%
(96.3–100.0)
78.1%
(60.0–90.7)
----

3.5.2. Using Combined Gold Standard

In the general population, the sensitivity of the POC-CCA test using a combined gold standard was 95.3% (95% CI: 93.4–96.9). For the HIV-1-seronegative group, the sensitivity of POC-CCA test was 95.7%. In the HIV-1-seropositive group, the sensitivity was 93.3%. The positive and negative predictive values for the general population and HIV-1-seropositive group are shown in Table 4.

3.5.3. Sensitivity of the Kato Katz Technique Using Combined Gold Standard

The sensitivity of the KK technique using the combined gold standard was 74.6% (95% CI: 70.9–77.9) in the general population, Table 5. In relation to HIV-1 serostatus, for the HIV-1-seronegative and -seropositive groups, the sensitivities were 79.7% and 49.5%. For the HIV-1-infected group, sensitivity was 49.5% (95% CI: 39.6–59.5). The positive and negative predictive values of the KK technique both in the general and HIV-1 seropositive group are shown in Table 5.

Table 5.

Sensitivity and specificity of the Kato Katz technique using a combined gold standard in a sub-population of study participants.

Sub-Population Sensitivity
% (95% CI)
Specificity
% (95% CI)
Positive Predictive Values
% (95% CI)
Negative Predictive Values
% (95% CI)
General population 74.6%
(70.9–77.9)
100%
(99.0–100.0)
100%
(99.2–100.0)
69.4%
(65.2–73.3)
HIV-1-seronegative 79.7%
(75.9–83.0)
100%
(98.9–100.0)
100%
(99.1–100.0)
76%
(71.7–80.0)
HIV-1-seropositive 49.5%
(39.6–59.5)
100%
(93.2–100.0)
100%
(93.2–100.0)
32.1%
(21.9–43.6)

4. Discussion

The main findings from this study indicate that the POC-CCA test is more sensitive than the parasitological KK technique in detecting S. mansoni infection among the general study population, specifically in the HIV-1/S. mansoni co-infected population. The sensitivity of the KK technique is relatively low, especially in the HIV-positive subpopulation, and the number of adult individuals detected with S. mansoni infection by the POC-CCA test was considerably higher than those detected using four KK thick smears. These results have implications for diagnostic methods to be used in mass screening programs in similar settings, especially among adult individuals.

Many studies in sub-Saharan Africa have recorded similar findings [17,19,20,21]. The performance of the POC-CCA test is influenced by the baseline intensity of S. mansoni infection [7]. The high sensitivity of the test is achieved in areas with a high intensity of infection [7] and in areas with a low intensity of S. mansoni infection, low test sensitivity has been reported [29]. In our study, the performance of the POC-CCA test was mainly influenced by the intensity of S. mansoni infection, and the majority of individuals with a low intensity of infection were missed by the test. The test missed very few individuals who had a moderate or heavy intensity of infection. Previous studies have demonstrated a positive relationship between the intensity of S. mansoni infection and positivity of the POC-CCA test [30,31]. We noted a low specificity of POC-CCA test and this partly is explained by the low sensitivities of the KK technique [7].

The use of the KK technique as a gold standard in evaluating the performance of other diagnostic tests has its limitations [6,25]. Thus, we developed an artificial gold standard, as previously described by Midzi et al. (2009) [26], to compare the diagnostic performance of the KK technique and POC-CCA test. Using the combined gold standard, the sensitivity of the POC-CCA test both in general and in the HIV-1 seropositive group improved markedly to >90%. The observed sensitivity was higher than that of the KK technique both in the general population and in the HIV-1-seropositive subgroup. Given the fact that adult individuals in S. mansoni-endemic areas are likely to carry a low intensity of infection and co-infections with HIV-1 affect the performance of the parasitological technique [9,11], the use of alternative diagnostic tests such as the POC-CCA test is highly recommended in the adult population.

Using the combined gold standard, the KK technique recorded very low sensitivity in the HIV-seropositive subpopulation, which was below 50%. Partly, reduced egg excretion efficiencies caused by the HIV-1 infection may explain the poor performance of the KK technique in the co-infected adult individuals [9,10,11,32]. Other authors have recorded a low sensitivity of the KK technique in pre-school children populations likely to have a low intensity of infection [18,29,33]. The performance of the KK technique appears to be influenced by the prevalence and S. mansoni intensity of infection or transmission intensity [34]. In areas were S. mansoni prevalence exceeds 50%, the performance of the KK technique yields results relatively similar to the POC-CCA test [34]. However, in areas with a lower prevalence of S. mansoni infection, the performance of the KK technique decreases whereas that of the POC-CCA test is increased [34]. If control programs adapt selective treatments based on parasitological results, a proportion of individuals would miss the treatment, especially in settings with a high HIV prevalence. This proportion will maintain transmission of the disease in that particular setting. Thus, employment of multiple diagnostic tests is highly recommended in epidemiological surveys to increase the chances of detecting targeted infection, especially in adult individuals likely to be have low infection intensity and to be co-infected with HIV-1. The use of multiple diagnostic tests (use of both tests in screening, or in case of limited funding, POC-CCA for screening, and KK for confirmation of diagnosis) allows a more accurate determination of disease burden when planning intervention programs [35]. However, POC-CCA is more expensive, and the control programs need to consider refunding. The cost of the POC-CCA test is about 5.00 USD under field conditions, whereas the cost for the KK technique is only about 1.50 USD per person.

In general, the KK technique has remained the diagnostic test of choice for epidemiological surveys aiming at estimating the prevalence and intensity of infection [6,18,29]. However, the sensitivity and specificity of the KK technique has remained a topic of discussion for many years [18,34,36]. Authors have documented its low sensitivity in detecting infection in individuals carrying low intensity of infections, especially young children and adult individuals likely to be co-infected with HIV-1 [18,34,36]. This makes the KK technique less useful in areas with low rates of transmission characterized by populations carrying low intensities of infection [18,34]. Partly, the low sensitivity of the KK technique is explained by the day-to-day variability in eggs output and the heterogeneous distribution of the S. mansoni eggs within the fecal samples [25].

Our study is subject to limitations. Considering the day-to-day variability of S. mansoni egg output [25], the use of a single stool sample to examine for S. mansoni infection may have led to an underestimation of the prevalence of S. mansoni using the KK technique. In addition, the low number of HIV-1/S. mansoni-co-infected individuals may have affected the power in assessing the sensitivity and specificity of the two tests. Considering the absence of a diagnostic standard, we combined both diagnostic tests to create an artificial gold standard. We are aware that this method is limited, as the tests—to some degree—are evaluated against their own results, and thus have taken care in the interpretation of respective study results. False-positive detection results can be considered as low, as the KK technique detects eggs of S. mansoni, and the POC-CCA specific antigens. Nevertheless, the data shows that a high number of diagnostic cases are missed by the use of only one method.

5. Conclusions

Considering the better diagnostic performance of POC-CCA, especially regarding the sensitivity in the HIV-positive population, and the high number of schistosomiasis cases missed by the KK technique in this group, POC-CCA should be used in screening programs in communities with a high prevalence of HIV infection. An approach using multiple testing techniques for the detection of schistosomiasis cases is recommended.

Acknowledgments

We thank the study participants from the study villages. We are grateful to the National Institute for Medical Research for laboratory work, logistical and financial management support. H.D.M. is a Senior Lecturer at School of Medicine, Catholic University of Health and Allied Sciences and Research Fellow at the National Institute for Medical Research, Mwanza, Tanzania. J.H. is a class 1 research fellow at Conselho Nacional de DesenvolvimentoCientífico e Tecnológico (CNPq/Brazil).

Author Contributions

H.D.M. conceived and designed the study, performed data collection, analyzed the data, and drafted the first version of the manuscript. J.H. analyzed the data, interpreted the results, and wrote the paper. Both authors read and approved the final manuscript, contributed to the critical review and contributed substantially to the work reported.

Funding

This work was supported by Training Health Researchers into Vocational Excellence in East Africa (THRiVE), grant number 087540, funded by the Wellcome Trust to H.D.M. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the supporting offices.

Conflicts of Interest

The authors declare no conflict of interest.

References

  • 1.Mazigo H.D., Nuwaha F., Kinung’hi S.M., Morona D., Pinot de Moira A., Wilson S., Heukelbach J., Dunne D.W. Epidemiology and control of human schistosomiasis in Tanzania. Parasites Vectors. 2012;5:274. doi: 10.1186/1756-3305-5-274. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Rollinson D., Knopp S., Levitz S., Stothard J.R., Tchuem Tchuente L.A., Garba A., Mohammed K.A., Schur N., Person B., Colley D.G., et al. Time to set the agenda for schistosomiasis elimination. Acta Trop. 2013;128:423–440. doi: 10.1016/j.actatropica.2012.04.013. [DOI] [PubMed] [Google Scholar]
  • 3.Mugono M., Konje E., Kuhn S., Mpogoro F.J., Morona D., Mazigo H.D. Intestinal schistosomiasis and geohelminths of Ukara Island, north-western Tanzania: Prevalence, intensity of infection and associated risk factors among school children. Parasites Vectors. 2014;7:612. doi: 10.1186/s13071-014-0612-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Malenganisho W.L., Magnussen P., Friis H., Siza J., Kaatano G., Temu M., Vennervald B.J. Schistosoma mansoni morbidity among adults in two villages along Lake Victoria shores in Mwanza District, Tanzania. Trans. R. Soc. Trop. Med. Hyg. 2008;102:532–541. doi: 10.1016/j.trstmh.2008.03.006. [DOI] [PubMed] [Google Scholar]
  • 5.Kardorff R., Gabone R.M., Mugashe C., Obiga D., Ramarokoto C.E., Mahlert C., Spannbrucker N., Lang A., Gunzler V., Gryseels B., et al. Schistosoma mansoni-related morbidity on Ukerewe Island, Tanzania: Clinical, ultrasonographical and biochemical parameters. Trop. Med. Intern. Health. 1997;2:230–239. doi: 10.1046/j.1365-3156.1997.d01-269.x. [DOI] [PubMed] [Google Scholar]
  • 6.Katz N., Chaves A., Pellegrino J. A simple device for quantitative stool thick-smear technique in Schistosomiasis mansoni. Rev. Inst. Med. Trop. Sao Paulo. 1972;14:397–400. [PubMed] [Google Scholar]
  • 7.Lamberton P.H., Kabatereine N.B., Oguttu D.W., Fenwick A., Webster J.P. Sensitivity and specificity of multiple Kato-Katz thick smears and a circulating cathodic antigen test for Schistosoma mansoni diagnosis pre- and post-repeated-praziquantel treatment. PLoS Negl. Trop. Dis. 2014;8:e3139. doi: 10.1371/journal.pntd.0003139. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Karanja D.M., Boyer A.E., Strand M., Colley D.G., Nahlen B.L., Ouma J.H., Secor W.E. Studies on schistosomiasis in western Kenya: II. Efficacy of praziquantel for treatment of schistosomiasis in persons coinfected with human immunodeficiency virus-1. Am. J. Trop. Med. Hyg. 1998;59:307–311. doi: 10.4269/ajtmh.1998.59.307. [DOI] [PubMed] [Google Scholar]
  • 9.Kallestrup P., Zinyama R., Gomo E., Butterworth A.E., van Dam G.J., Erikstrup C., Ullum H. Schistosomiasis and HIV-1 infection in rural Zimbabwe: Implications of coinfection for excretion of eggs. J. Infect. Dis. 2005;191:1311–1320. doi: 10.1086/428907. [DOI] [PubMed] [Google Scholar]
  • 10.Mazigo H.D., Dunne D.W., Wilson S., Kinung’hi S.M., Pinot de Moira A., Jones F.M., Morona D., Nuwaha F. Co-infection with Schistosoma mansoni and human immunodeficiency virus-1 (HIV-1) among residents of fishing villages of north-western Tanzania. Parasites Vectors. 2014;7:587. doi: 10.1186/s13071-014-0587-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Karanja D.M., Colley D.G., Nahlen B.L., Ouma J.H., Secor W.E. Studies on schistosomiasis in western Kenya: I. Evidence for immune-facilitated excretion of schistosome eggs from patients with Schistosoma mansoni and human immunodeficiency virus coinfections. Am. J. Trop. Med. Hyg. 1997;56:515–521. doi: 10.4269/ajtmh.1997.56.515. [DOI] [PubMed] [Google Scholar]
  • 12.Dunne D.W., Hassounah O., Musallam R., Lucas S., Pepys M.B., Baltz M., Doenhoff M. Mechanisms of Schistosoma mansoni egg excretion: Parasitological observations in immunosuppressed mice reconstituted with immune serum. Parasites Immunol. 1983;5:47–60. doi: 10.1111/j.1365-3024.1983.tb00722.x. [DOI] [PubMed] [Google Scholar]
  • 13.Mazigo H.D., Nuwaha F., Wilson S., Kinung’hi S.M., Morona D., Waihenya R., Heukelbach J., Dunne D.W. Epidemiology and interactions of human immunodeficiency virus-1 and Schistosoma mansoni in sub-Saharan Africa. Infect. Dis. Poverty. 2013;2:2. doi: 10.1186/2049-9957-2-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Mazigo H.D., Dunne D.W., Morona D., Lutufyo T.E., Kinung’hi S.M., Kaatano G., Nuwaha F. Periportal fibrosis, liver and spleen sizes among S. mansoni mono- or co-infected individuals with human immunodeficiency virus-1 in fishing villages along Lake Victoria shores, north-western Tanzania. Parasites Vectors. 2015;8:260. doi: 10.1186/s13071-015-0876-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Van Dam G., Wichers J., Ferreira T.F., Ghati D., Van Amerongen A., Deelder A. Diagnosis of schistosomiasis by reagent strip test for detection of circulating cathodic antigen. J. Clin. Microbiol. 2004;42:5458–5461. doi: 10.1128/JCM.42.12.5458-5461.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Stothard J.R., Kabatereine N.B., Tukahebwa E.M., Kazibwe F., Rollinson D., Mathieson W., Webster J.P., Fenwick A. Use of circulating cathodic antigen (CCA) dipsticks for detection of intestinal and urinary schistosomiasis. Acta Trop. 2006;97:219–228. doi: 10.1016/j.actatropica.2005.11.004. [DOI] [PubMed] [Google Scholar]
  • 17.Danso-Appiah A., Minton J., Boamah D., Otchere J., Asmah R.H., Rodgers M., Bosompem K.M., Eusebi P., De Vlas S.J. Accuracy of point-of-care testing for circulatory cathodic antigen in the detection of schistosome infection: Systematic review and meta-analysis. Bull. World Health Organ. 2016;94:522A–533A. doi: 10.2471/BLT.15.158741. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Okoyo C., Simiyu E., Njenga S.M., Mwandawiro C. Comparing the performance of circulating cathodic antigen and Kato-Katz techniques in evaluating Schistosoma mansoni infection in areas with low prevalence in selected counties of Kenya: A cross-sectional study. BMC Public Health. 2018;18:478. doi: 10.1186/s12889-018-5414-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Lindholz C.G., Favero V., Verissimo C.M., Candido R.R.F., de Souza R.P., Dos Santos R.R., Morassutti A.L., Bittencourt H.R., Jones M.K., St Pierre T.G., et al. Study of diagnostic accuracy of Helmintex, Kato-Katz, and POC-CCA methods for diagnosing intestinal schistosomiasis in Candeal, a low intensity transmission area in northeastern Brazil. PLoS Negl. Trop. Dis. 2018;12:e0006274. doi: 10.1371/journal.pntd.0006274. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Clements M.N., Corstjens P., Binder S., Campbell C.H., Jr., de Dood C.J., Fenwick A., Harrison W., Kayugi D., King C.H., Kornelis D., et al. Latent class analysis to evaluate performance of point-of-care CCA for low-intensity Schistosoma mansoni infections in Burundi. Parasites Vectors. 2018;11:111. doi: 10.1186/s13071-018-2700-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Ferreira F.T., Fidelis T.A., Pereira T.A., Otoni A., Queiroz L.C., Amancio F.F., Antunes C.M., Lambertucci J.R. Sensitivity and specificity of the circulating cathodic antigen rapid urine test in the diagnosis of Schistosomiasis mansoni infection and evaluation of morbidity in a low-endemic area in Brazil. Rev. Soc. Bras. Med. Trop. 2017;50:358–364. doi: 10.1590/0037-8682-0423-2016. [DOI] [PubMed] [Google Scholar]
  • 22.Mazigo H., Dunne D.W., Kinung’hi S.M., Fred N. Praziquantel efficacy against Schistosoma mansoni among HIV-1 infected and uninfected adults living in fishing villages along Lake Victoria, northwest Tanzania. Infect. Dis. Poverty. 2014;3:47. doi: 10.1186/2049-9957-3-47. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Lyamuya E.F., Aboud S., Urassa W.K., Sufi J., Mbwana J., Ndugulile F., Massambu C. Evaluation of simple rapid HIV assays and development of national rapid HIV test algorithms in Dar es Salaam, Tanzania. BMC Infect. Dis. 2009;9:19. doi: 10.1186/1471-2334-9-19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.World Health Organization . World Health Organization Technical Report Series. Volume 912. World Health Organization; Geneva, Switzerland: 2002. Prevention and control of schistosomiasis and soil-transmitted helminthiasis. [PubMed] [Google Scholar]
  • 25.Berhe N., Medhin G., Erko B., Smith T., Gedamu S., Bereded D., Moore R., Habte E., Redda A., Gebre-Michael T. Variations in helminth faecal egg counts in Kato–Katz thick smears and their implications in assessing infection status with Schistosoma mansoni. Acta Trop. 2004;92:205–212. doi: 10.1016/j.actatropica.2004.06.011. [DOI] [PubMed] [Google Scholar]
  • 26.Midzi N., Butterworth A.E., Mduluza T., Munyati S., Deelder A.M., van Dam G.J. Use of circulating cathodic antigen strips for the diagnosis of urinary schistosomiasis. Trans. R. Soc. Trop. Med. Hyg. 2009;103:45–51. doi: 10.1016/j.trstmh.2008.08.018. [DOI] [PubMed] [Google Scholar]
  • 27.Nausch N., Dawson E.M., Midzi N., Mduluza T., Mutapi F., Doenhoff M. Field evaluation of a new antibody-based diagnostic for Schistosoma haematobium and S. mansoni at the point-of-care in northeast Zimbabwe. BMC Infect. Dis. 2014;14:165. doi: 10.1186/1471-2334-14-165. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Landis J.R.K.G. An application of hierarchical kappa-type statistics in the assessment of majority agreement among multiple observers. Biometrics. 1977;33:363–374. doi: 10.2307/2529786. [DOI] [PubMed] [Google Scholar]
  • 29.Coulibaly J.T., Knopp S., N’Guessan N.A., Silue K.D., Furst T., Lohourignon L.K., Brou J.K., N’Gbesso Y.K., Vounatsou P., N’Goran E.K., et al. Accuracy of urine circulating cathodic antigen (CCA) test for Schistosoma mansoni diagnosis in different settings of Cote d’Ivoire. PLoS Negl. Trop. Dis. 2011;5:e1384. doi: 10.1371/journal.pntd.0001384. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Silveira A.M., Costa E.G., Ray D., Suzuki B.M., Hsieh M.H., Fraga L.A., Caffrey C.R. Evaluation of the CCA immuno-chromatographic test to diagnose Schistosoma mansoni in Minas Gerais State, Brazil. PLoS Negl. Trop. Dis. 2016;10:e0004357. doi: 10.1371/journal.pntd.0004357. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Mwinzi P.N., Kittur N., Ochola E., Cooper P.J., Campbell C.H., Jr., King C.H., Colley D.G. Additional evaluation of the point-of-contact circulating cathodic antigen assay for Schistosoma mansoni infection. Front. Public Health. 2015;3:48. doi: 10.3389/fpubh.2015.00048. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Fontanet A.L., Woldemichael T., Sahlu T., van Dam G.J., Messele T., Rinke de Wit T., Masho W., Yeneneh H., Coutinho R.A., van Lieshout L. Epidemiology of HIV and Schistosoma mansoni infections among sugar-estate residents in Ethiopia. Ann. Trop. Med. Parasitol. 2000;94:145–155. doi: 10.1080/00034983.2000.11813523. [DOI] [PubMed] [Google Scholar]
  • 33.Coulibaly J.T., N’Gbesso Y.K., Knopp S., N’Guessan N.A., Silue K.D., van Dam G.J., N’Goran E.K., Utzinger J. Accuracy of urine circulating cathodic antigen test for the diagnosis of Schistosoma mansoni in preschool-aged children before and after treatment. PLoS Negl. Trop. Dis. 2013;7:e2109. doi: 10.1371/journal.pntd.0002109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Kittur N., Castleman J.D., Campbell C.H., Jr., King C.H., Colley D.G. Comparison of Schistosoma mansoni Prevalence and intensity of infection, as determined by the circulating cathodic antigen urine assay or by the Kato-Katz fecal assay: A systematic review. Am. J. Trop. Med. Hyg. 2016;94:605–610. doi: 10.4269/ajtmh.15-0725. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Lodh N., Mwansa J.C., Mutengo M.M., Shiff C.J. Diagnosis of Schistosoma mansoni without the stool: Comparison of three diagnostic tests to detect Schistosoma [corrected] mansoni infection from filtered urine in Zambia. Am. J. Trop. Med. Hyg. 2013;89:46–50. doi: 10.4269/ajtmh.13-0104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.De Vlas S.J., Gryseels B. Underestimation of Schistosoma mansoni prevalences. Parasitol. Today. 1992;8:274–277. doi: 10.1016/0169-4758(92)90144-Q. [DOI] [PubMed] [Google Scholar]

Articles from Tropical Medicine and Infectious Disease are provided here courtesy of Multidisciplinary Digital Publishing Institute (MDPI)

RESOURCES